Evidence map›Paper›PMID 38358637›Full record

ReviewCurrent oncology reports2024

Establishing an Integrative Oncology Service: Essential Aspects of Program Development.

Judith Lacey, Alissa Huston, Gabriel Lopez, Julia Ruiz Vozmediano, Chun Sing Lam, Santhosshi Narayanan, Weidong Lu, Ursula Wolf, Ishwaria M Subbiah, Patrick Richard and 3 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current oncology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. A Comprehensive Review on Anticancer Potential ofCurrent cancer drug targets · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 5 countries.

Judith Lacey *Supportive Care and Integrative Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia.ORCID 0000-0002-3751-406X
Alissa Huston *Pluta Integrative Oncology & Wellness Center, Wilmot Cancer Institute University of Rochester, Rochester, NY, USA.ORCID 0009-0004-5247-9567
Gabriel Lopez *Integrative Medicine Center, Department of Palliative, Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-3685-0280
Julia Ruiz VozmedianoOnconature Integrative Oncology Center Orgiva, Granada, Spain.ORCID 0000-0002-9516-8046
Chun Sing LamSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.ORCID 0000-0002-6478-6706
Santhosshi NarayananIntegrative Medicine Center, Department of Palliative, Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-0591-1500
Weidong LuZakim Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-2838-6307
Ursula WolfInstitute of Complementary and Integrative Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0002-1602-1143
Ishwaria M SubbiahCancer Care Equity and Professional Wellness, Sarah Cannon Research Institute, Nashville, TN, USA.
Patrick RichardRadiation Oncology, Rocky Mountain Cancer Centers, Boulder, CO, USA.
Ana Maria LopezIntegrative Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Cherry Hill, Cherry Hill, NJ, USA.ORCID 0000-0002-2759-5353
Santosh RaoIntegrative Oncology, University Hospitals Connor Whole Health. Beachwood, Beachwood, OH, USA.
Moshe FrenkelComplementary and Integrative Medicine Service, Oncology Division, Rambam Health Care Campus, Haifa, Israel. frenkelm@netvision.net.il.ORCID 0000-0002-0245-0764
The University of Texas MD Anderson Cancer Center · USChinese University of Hong Kong · HKChris O’Brien Lifehouse · AUHarvard University · USRambam Health Care Campus · ILRocky Mountain Cancer Centers · USSarah Cannon · USThomas Jefferson University · USUniversity of Bern · CHUniversity of Rochester · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewOver the last 2 decades, integrative oncology (IO) has seen exponential growth within cancer care. It aims to combine evidence-based complementary therapies with conventional treatments to improve the well-being and quality of life for individuals dealing with cancer. The proliferation of integrative medicine programs in major cancer centers globally reflects varying approaches shaped by cultural, demographic, and resource-based factors. RECENT

findingsDrawing upon the expertise of leaders in IO from the Society for Integrative Oncology (SIO) Clinical Practice Committee, this manuscript serves as a practical guide for establishing an IO practice. Collating insights from diverse professionals, including oncologists, integrative oncologists, supportive care physicians, researchers, and clinicians, the paper aims to provide a comprehensive roadmap for initiating and advancing IO services. The primary objective is to bridge the gap between conventional cancer care and complementary therapies, fostering a patient-centric approach to address the multifaceted challenges encountered by individuals with cancer. This paper delineates several key sections elucidating different aspects of IO practice. It delves into the core components necessary for an IO service's foundation, outlines the initial medical consultation process, and presents crucial tools essential for successful consultations. By consolidating insights and expertise, this manuscript seeks to facilitate the integration of IO into mainstream cancer care, ultimately enhancing patient outcomes and experiences.

Indexed as

Complementary TherapiesIntegrative MedicineIntegrative OncologyNeoplasmsHumansProgram DevelopmentQuality of LifeCancer careComplementary medicineIntegrative oncologyPatient-centered carePractice guidelinesSupportive care

Identifiers

PMID38358637
OpenAlexW4391842849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.